U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07809490) titled 'Admission, Triage, and Discharge Criteria for Oncological Patients in the Intensive Care U... Read More
Singapore, Sept. 10 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the e... Read More
U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07809282) titled 'A Study of Mitragynine Formulations for Exercise-Induced Muscle Soreness in Healthy Adults... Read More
Singapore, Sept. 10 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investiga... Read More
Singapore, Sept. 10 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate ... Read More
U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07808541) titled 'Juntas Adelante: A Peer-Coaching Intervention to Promote Chemoprophylaxis for HIV Preventi... Read More
U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07810439) titled 'PROTECT-Africa: Biomarker Validation for Preeclampsia Triage' on Sept. 03. Brief Summary:... Read More
U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07809334) titled 'Implant Survival After Surgical Treatment of Peri-implantitis of Infra-bony Defects' on Au... Read More
U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07810816) titled 'Prospective Pharmacogenetic Cohort Study of CYP2D6 Metabolizer Phenotype, Analgesic Failur... Read More
U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07811063) titled 'A Study to Test a Single Dose of a New Tablet Formulation of TRTL-729' on Sept. 02. Brief... Read More